A novel PEG-PLE/C14-PEI nanoplex formulation for delivering Cas9 mRNA and sgRNA, targeting KRAS G12S mutations in lung cancer cells demonstrates high gene-editing efficiency and significantly enhanced cancer cell apoptosis and migration inhibition. This evidence concerns the gene KRAS and cancer.